Trials / Withdrawn
WithdrawnNCT02060734
Lidocaine Injection Versus Sham Needling in Treating Whiplash Associated Disorder
Lidocaine Injection Versus Sham Needling in Treating Whiplash Associated disorder-a Randomized Controlled Trial
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Hamilton Health Sciences Corporation · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To determine the efficacy of lidocaine injection of trigger points versus subcutaneous injection in patients with subacute whiplash associated disorder following injury.
Detailed description
This is a double-blind, randomized controlled trial to determine the efficacy of lidocaine injection of trigger points versus subcutaneous injection in patients with subacute whiplash associated disorder following injury. Outcomes include pain, objective assessment, self-report function recovery, impact on work performance and globe perceived effects which will be assessed 5 minutes, 2 and 6 weeks following injection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Lidocaine | Lidocaine injection 3-5 points in experimental group( using 25 gauge, 40mm long needle, pre-filled with 1% lidocaine inserting into the site of the trigger point). |
| OTHER | Saline | The control group will receive a 25 gauge, 40mm long needle, pre-filled with saline inserting to subcutis. |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2016-01-01
- Completion
- 2016-09-01
- First posted
- 2014-02-12
- Last updated
- 2017-02-23
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT02060734. Inclusion in this directory is not an endorsement.